A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial
- PMID: 17336650
- DOI: 10.1016/S0140-6736(07)60360-2
A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial
Abstract
Background: Mild in-vitro fertilisation (IVF) treatment might lessen both patients' discomfort and multiple births, with their associated risks. We aimed to test the hypothesis that mild IVF treatment can achieve the same chance of a pregnancy resulting in term livebirth within 1 year compared with standard treatment, and can also reduce patients' discomfort, multiple pregnancies, and costs.
Methods: We did a randomised, non-inferiority effectiveness trial. 404 patients were randomly assigned to undergo either mild treatment (mild ovarian stimulation with gonadotropin-releasing hormone [GnRH] antagonist co-treatment combined with single embryo transfer) or a standard treatment (stimulation with a GnRH agonist long-protocol and transfer of two embryos). Primary endpoints were proportion of cumulative pregnancies leading to term livebirth within 1 year after randomisation (with a non-inferiority threshold of -12.5%), total costs per couple up to 6 weeks after expected date of delivery, and overall discomfort for patients. Analysis was by intention to treat. This trial is registered as an International Standard Randomised Clinical Trial, number ISRCTN35766970.
Findings: The proportions of cumulative pregnancies that resulted in term livebirth after 1 year were 43.4% with mild treatment and 44.7% with standard treatment (absolute number of patients=86 for both groups). The lower limit of the one-sided 95% CI was -9.8%. The proportion of couples with multiple pregnancy outcomes was 0.5% with mild IVF treatment versus 13.1% (p<0.0001) with standard treatment, and mean total costs were 8333 euros and 10745 euros, respectively (difference 2412 euros, 95% CI 703-4131). There were no significant differences between the groups in the anxiety, depression, physical discomfort, or sleep quality of the mother.
Interpretation: Over 1 year of treatment, cumulative rates of term livebirths and patients' discomfort are much the same for mild ovarian stimulation with single embryos transferred and for standard stimulation with two embryos transferred. However, a mild IVF treatment protocol can substantially reduce multiple pregnancy rates and overall costs.
Republished in
-
[Reduction of patient discomfort, risks and costs, but not pregnancies, by a mild strategy for in-vitro fertilisation].Ned Tijdschr Geneeskd. 2008 Apr 5;152(14):809-16. Ned Tijdschr Geneeskd. 2008. PMID: 18491824 Dutch.
Comment in
-
Favourable outcomes from "mild" in-vitro fertilisation.Lancet. 2007 Mar 3;369(9563):717-718. doi: 10.1016/S0140-6736(07)60332-8. Lancet. 2007. PMID: 17336628 No abstract available.
-
Mild versus standard in-vitro fertilisation techniques.Lancet. 2007 Jun 2;369(9576):1855. doi: 10.1016/S0140-6736(07)60839-3. Lancet. 2007. PMID: 17544754 No abstract available.
-
Mild versus standard in-vitro fertilisation techniques.Lancet. 2007 Jun 2;369(9576):1855. doi: 10.1016/S0140-6736(07)60838-1. Lancet. 2007. PMID: 17544756 No abstract available.
Similar articles
-
[Reduction of patient discomfort, risks and costs, but not pregnancies, by a mild strategy for in-vitro fertilisation].Ned Tijdschr Geneeskd. 2008 Apr 5;152(14):809-16. Ned Tijdschr Geneeskd. 2008. PMID: 18491824 Dutch.
-
Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint.Hum Reprod. 2008 Feb;23(2):316-23. doi: 10.1093/humrep/dem372. Epub 2007 Nov 22. Hum Reprod. 2008. PMID: 18033807 Clinical Trial.
-
A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial.Hum Reprod. 2017 Jan;32(1):112-118. doi: 10.1093/humrep/dew282. Epub 2016 Nov 11. Hum Reprod. 2017. PMID: 27836979 Clinical Trial.
-
Addressing the dramatic rise in multiple pregnancies.Hosp Pract (1995). 2000 Apr 15;35(4):124-6, 129-30, 133-4. doi: 10.3810/hp.2000.04.191. Hosp Pract (1995). 2000. PMID: 10780188 Review.
-
Should mild stimulation be the order of the day?J Hum Reprod Sci. 2013 Oct;6(4):220-6. doi: 10.4103/0974-1208.126282. J Hum Reprod Sci. 2013. PMID: 24672159 Free PMC article. Review.
Cited by
-
Decrease in preovulatory serum estradiol is a valuable marker for predicting premature ovulation in natural/unstimulated in vitro fertilization cycle.J Ovarian Res. 2018 Nov 21;11(1):96. doi: 10.1186/s13048-018-0469-x. J Ovarian Res. 2018. PMID: 30463583 Free PMC article.
-
Controlled Ovarian Stimulation Protocols Alter Endometrial Histomorphology and Gene Expression Profiles.Reprod Sci. 2020 Mar;27(3):895-904. doi: 10.1007/s43032-019-00093-6. Epub 2020 Jan 6. Reprod Sci. 2020. PMID: 32046444 Free PMC article.
-
Testing for Ovarian Reserve in Assisted Reproduction programs: the current point of view.Facts Views Vis Obgyn. 2009;1(2):79-87. Facts Views Vis Obgyn. 2009. PMID: 25478073 Free PMC article.
-
Uterine selection of human embryos at implantation.Sci Rep. 2014 Feb 6;4:3894. doi: 10.1038/srep03894. Sci Rep. 2014. PMID: 24503642 Free PMC article.
-
Women Undergoing Hormonal Treatments for Infertility: A Systematic Review on Psychopathology and Newly Diagnosed Mood and Psychotic Disorders.Front Psychiatry. 2020 May 26;11:479. doi: 10.3389/fpsyt.2020.00479. eCollection 2020. Front Psychiatry. 2020. PMID: 32528332 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical